Benefits of lifestyle modification in NAFLD
- PMID: 17911352
- PMCID: PMC2095707
- DOI: 10.1136/gut.2006.112094
Benefits of lifestyle modification in NAFLD
Conflict of interest statement
Competing interests: CPD has acted as a consultant for several pharmaceutical companies interested in developing drugs for the treatment of fatty liver disease: Sanofi‐Aventis, Astellas and Pfizer. SAH has acted as a consultant for several pharmaceutical companies interested in developing drugs for the treatment of non‐alcoholic fatty liver disease: Sanofi‐Aventis and Schering‐Plough.
Figures
Similar articles
-
Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?World J Gastroenterol. 2012 Dec 14;18(46):6790-800. doi: 10.3748/wjg.v18.i46.6790. World J Gastroenterol. 2012. PMID: 23239917 Free PMC article. Review.
-
Non-alcoholic fatty liver disease and insulin resistance.Eur J Gastroenterol Hepatol. 2005 Aug;17(8):823-6. doi: 10.1097/00042737-200508000-00008. Eur J Gastroenterol Hepatol. 2005. PMID: 16003131 Review.
-
Physical activity: an essential component of lifestyle modification in NAFLD.Nat Rev Gastroenterol Hepatol. 2012 Dec;9(12):726-31. doi: 10.1038/nrgastro.2012.200. Epub 2012 Oct 23. Nat Rev Gastroenterol Hepatol. 2012. PMID: 23090329 Review.
-
[Treatment of NASH: nutritional counseling and physical exercise].Nihon Rinsho. 2006 Jun;64(6):1139-45. Nihon Rinsho. 2006. PMID: 16768122 Review. Japanese.
-
[Pathogenesis and treatment of non-alcoholic fatty liver disease].Zhong Xi Yi Jie He Xue Bao. 2010 Mar;8(3):201-9. doi: 10.3736/jcim20100301. Zhong Xi Yi Jie He Xue Bao. 2010. PMID: 20226139 Review. Chinese.
Cited by
-
Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease.J Clin Endocrinol Metab. 2013 Jul;98(7):E1181-8. doi: 10.1210/jc.2013-1229. Epub 2013 Apr 24. J Clin Endocrinol Metab. 2013. PMID: 23616151 Free PMC article.
-
Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease.Liver Int. 2024 Oct;44(10):2807-2821. doi: 10.1111/liv.16055. Epub 2024 Jul 31. Liver Int. 2024. PMID: 39082383
-
Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?J Endocrinol Invest. 2011 Jul-Aug;34(7):544-51. doi: 10.3275/7614. Epub 2011 Mar 21. J Endocrinol Invest. 2011. PMID: 21427524 Review.
-
Hypertension and hepatic steatosis.Curr Hypertens Rep. 2008 Jun;10(3):182-7. doi: 10.1007/s11906-008-0035-9. Curr Hypertens Rep. 2008. PMID: 18765087 Review.
-
Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.Integr Med (Encinitas). 2015 Feb;14(1):25-33. Integr Med (Encinitas). 2015. PMID: 26770128 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources